Literature DB >> 10683411

Inhibitory glutamatergic regulation of evoked dopamine release in striatum.

Y Wu1, S M Pearl, M J Zigmond, A C Michael.   

Abstract

Certain aspects of schizophrenia and Parkinson's disease suggest that glutamate might have an inhibitory effect on dopamine release. Several studies have reported that the excitatory actions of ionotropic glutamate agonists on extracellular dopamine levels in striatum are resistant to tetrodotoxin, which suggests that glutamate excites an impulse-independent mechanism of dopamine release. We tested the hypothesis that an inhibitory action of glutamate on dopamine terminals in the striatum specifically involves an impulse-dependent mechanism of dopamine release. We used voltammetry to monitor electrically-evoked dopamine release in striatal slices, which is completely tetrodotoxin- and Ca(2+)-sensitive and so provides a model of impulse-dependent dopamine release. Agonists of the ionotropic glutamate receptors significantly decreased the amplitude of the response, while antagonists significantly increased the amplitude of the response, by as much as approximately 60% in the case of kynurenic acid. These results support the hypothesis that ionotropic glutamate receptors can inhibit impulse-dependent dopamine release by a mechanism that acts locally within the striatum. This finding contrasts with previous reports that glutamate can excite impulse-independent dopamine release. This extends earlier findings that glutamate may both excite and inhibit subcortical dopamine systems by suggesting that the excitatory and inhibitory actions of striatal ionotropic glutamate receptors are specifically associated with impulse-independent and impulse-dependent dopamine release, respectively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683411     DOI: 10.1016/s0306-4522(99)00539-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

Review 1.  Monitoring rapid chemical communication in the brain.

Authors:  Donita L Robinson; Andre Hermans; Andrew T Seipel; R Mark Wightman
Journal:  Chem Rev       Date:  2008-06-25       Impact factor: 60.622

2.  Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2.

Authors:  Marat V Avshalumov; Billy T Chen; Sarah P Marshall; Dianna M Peña; Margaret E Rice
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

3.  Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo.

Authors:  Eric S Ramsson; Daniel P Covey; David P Daberkow; Melissa T Litherland; Steven A Juliano; Paul A Garris
Journal:  J Neurochem       Date:  2011-05-03       Impact factor: 5.372

Review 4.  Direct dopamine terminal regulation by local striatal microcircuitry.

Authors:  Suzanne O Nolan; Jennifer E Zachry; Amy R Johnson; Lillian J Brady; Cody A Siciliano; Erin S Calipari
Journal:  J Neurochem       Date:  2020-06-19       Impact factor: 5.372

5.  Vesicular Antipsychotic Drug Release Evokes an Extra Phase of Dopamine Transmission.

Authors:  Seth H Walters; Edwin S Levitan
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

6.  Diffuse brain injury elevates tonic glutamate levels and potassium-evoked glutamate release in discrete brain regions at two days post-injury: an enzyme-based microelectrode array study.

Authors:  Jason M Hinzman; Theresa Currier Thomas; Jason J Burmeister; Jorge E Quintero; Peter Huettl; Francois Pomerleau; Greg A Gerhardt; Jonathan Lifshitz
Journal:  J Neurotrauma       Date:  2010-05       Impact factor: 5.269

7.  Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors.

Authors:  Hui Zhang; David Sulzer
Journal:  Basal Ganglia       Date:  2012-03-01

8.  Disparity between tonic and phasic ethanol-induced dopamine increases in the nucleus accumbens of rats.

Authors:  Donita L Robinson; Elaina C Howard; Scott McConnell; Rueben A Gonzales; R Mark Wightman
Journal:  Alcohol Clin Exp Res       Date:  2009-04-09       Impact factor: 3.455

9.  Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatum.

Authors:  Karl B Scheidweiler; Bruce Ladenheim; Jean Lud Cadet; Marilyn A Huestis
Journal:  Neurotox Res       Date:  2009-10-23       Impact factor: 3.911

10.  Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects.

Authors:  Sumie Leung; Rodney J Croft; Torsten Baldeweg; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2007-07-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.